Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Mabwell

Immunology

Immunology Today—May 13, 2026

This week’s Immunology update highlights regulatory actions, clinical progress,…

Women's_Health

Women’s Health Today—April 29, 2026

This biweekly Women’s Health video recap highlights regulatory actions, access…

Onco_background

Oncology Today—April 27, 2026

This week’s Oncology update highlights regulatory approvals, late-stage trial…

Respiratory

Respiratory Today—January 9, 2026

This respiratory update spotlights reflects strong momentum across respiratory…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: AlzeCure Pharma Collaboration and Out-Licensing Agreement with Eli Lilly
Obesity Today—June 9, 2026
Endocrinology Today—June 9, 2026
Pfizer’s HYMPAVZI FDA label expansion | Lucid Diligence Brief
Oncology Today—June 8, 2026

Tags

AANAM ADHD Aging Research ALTO-101 Atirmociclib ATS 2025 BAG3-Associated Dilated Cardiomyopathy Bavarian Nordic Belimumab Bone Marrow Transplant catalysts Competitive Intelligence Tools Dravet Syndrome Durvalumab Dyno Therapeutics Gotenfia Gut Brain Axis HIV capsid HIV prevention Iberdomide Insulin delivery systems intracardiac echocardiography LQ Ventures Mira-55 Oncology Research pain management Patient Narrative pediatric rare diseases Postpartum Depression Predictive toxicology probiotics rare conditions Renal Denervation RNA RNA therapies ROCTAVIAN Schizophrenia Research SLK antibody Statins Taltz TAVI Teva Pharmaceutical Industries UP421 wearable health Zenyaku Kogyo

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: AlzeCure Pharma Collaboration and Out-Licensing Agreement with Eli Lilly
Obesity Today—June 9, 2026
Endocrinology Today—June 9, 2026
Pfizer’s HYMPAVZI FDA label expansion | Lucid Diligence Brief
Oncology Today—June 8, 2026

TAGS

AANAM ADHD Aging Research ALTO-101 Atirmociclib ATS 2025 BAG3-Associated Dilated Cardiomyopathy Bavarian Nordic Belimumab Bone Marrow Transplant catalysts Competitive Intelligence Tools Dravet Syndrome Durvalumab Dyno Therapeutics Gotenfia Gut Brain Axis HIV capsid HIV prevention Iberdomide Insulin delivery systems intracardiac echocardiography LQ Ventures Mira-55 Oncology Research pain management Patient Narrative pediatric rare diseases Postpartum Depression Predictive toxicology probiotics rare conditions Renal Denervation RNA RNA therapies ROCTAVIAN Schizophrenia Research SLK antibody Statins Taltz TAVI Teva Pharmaceutical Industries UP421 wearable health Zenyaku Kogyo

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy